Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

MJ Stone, EA Sausville, JW Fay, D Headlee, RH Collins, WD Figg, M Stetler- Stevenson, V Jain, ES Jaffe, D Solomon, RM Lush, A Senderowicz, V Ghetie, J Schindler, JW Uhr, ES Vitetta

Blood (1996) 88 (4): 1188–1197.

https://doi.org/10.1182/blood.V88.4.1188.bloodjournal8841188

Published: 1996

Journal Articles

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

MA Ghetie, K Tucker, J Richardson, JW Uhr, ES Vitetta

Blood (1994) 84 (3): 702–707.

https://doi.org/10.1182/blood.V84.3.702.702

Published: 1994

Journal Articles

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

MA Ghetie, LJ Picker, JA Richardson, K Tucker, JW Uhr, ES Vitetta

Blood (1994) 83 (5): 1329–1336.

https://doi.org/10.1182/blood.V83.5.1329.1329

Published: 1994

Journal Articles

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

MA Ghetie, K Tucker, J Richardson, JW Uhr, ES Vitetta

Blood (1992) 80 (9): 2315–2320.

https://doi.org/10.1182/blood.V80.9.2315.2315

Published: 1992

Journal Articles

Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow

M Muirhead, PJ Martin, B Torok-Storb, JW Uhr, ES Vitetta

Blood (1983) 62 (2): 327–332.

https://doi.org/10.1182/blood.V62.2.327.327

Published: 1983

Journal Articles

Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess"

FS Ligler, RG Smith, JR Kettman, JA Hernandez, JB Himes, ES Vitetta, JW Uhr, EP Frenkel

Blood (1980) 55 (5): 792–801.

https://doi.org/10.1182/blood.V55.5.792.792

Published: 1980

NARROW

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow

Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess"

Email alerts

ASH Publications

American Society of Hematology

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow

Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess"

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only